Stryker Corp Fourth Quarter Earnings Sneak Peek

S&P 500 (NYSE:SPY) component Stryker Corp (NYSE:SYK) will unveil its latest earnings on Tuesday, January 24, 2012. Stryker is a medical technology firm that produces a range of products in medical implants, surgical technologies and emergency medical equipment.

Stryker Corp Earnings Preview Cheat Sheet.

Wall St. Earnings Expectations: The average estimate of analysts is for profit of $1.03 per share, a rise of 10.8% from the company’s actual earnings for the same quarter a year ago. The average estimate is the same as three months ago. Between one and three months ago, the average estimate was unchanged. It also has not changed during the last month. For the year, analysts are projecting net income of $3.73 per share, a rise of 12% from last year.

Past Earnings Performance: Last quarter, the company topped estimates by 0 cents, coming in at profit of 91 cents per share against a mean estimate of net income of 89 cents. The company fell in line with estimates in the second quarter.

Investing Insights: Will the iPad 3 Be the Next Catalyst for Apple’s Stock?

Wall St. Revenue Expectations: On average, analysts predict $2.22 billion in revenue this quarter, a rise of 11% from the year ago quarter. Analysts are forecasting total revenue of $8.31 billion for the year, a rise of 13.5% from last year’s revenue of $7.32 billion.

Analyst Ratings: Analysts are bullish on this stock with 21 analysts rating it as a buy, none rating it as a sell and seven rating it as a hold.

A Look Back: In the third quarter, profit fell 3.2% to $327 million (84 cents a share) from $337.7 million (85 cents a share) the year earlier, but exceeded analyst expectations. Revenue rose 14.9% to $2.03 billion from $1.77 billion.

Key Stats:

Revenue has risen the past four quarters. Revenue rose 16.3% in the second quarter from the year earlier, climbed 12% in the first quarter from the year-ago quarter and 8.8% in the fourth quarter of the last fiscal year.

While the company has been profitable for the last eight quarters, income has fallen year over year by an average of 3.6% over the past four quarters. The quarter hit the hardest was the first quarter, that saw a 4.4% drop.

Competitors to Watch: Zimmer Holdings, Inc. (NYSE:ZMH), Exactech, Inc. (NASDAQ:EXAC), Smith & Nephew plc (NYSE:SNN), Wright Medical Group, Inc. (NASDAQ:WMGI), Tornier N.V. (NASDAQ:TRNX), CONMED Corporation (NASDAQ:CNMD), ArthroCare Corporation (NASDAQ:ARTC), Medtronic, Inc. (NYSE:MDT), NuVasive, Inc. (NASDAQ:NUVA), and Alphatec Holdings, Inc. (NASDAQ:ATEC).

Stock Price Performance: During December 16, 2011 to January 18, 2012, the stock price had risen $6.16 (13.4%) from $46.01 to $52.17. The stock price saw one of its best stretches over the last year between October 3, 2011 and October 13, 2011 when shares rose for nine-straight days, rising 10.7% (+$4.81) over that span. It saw one of its worst periods between December 9, 2011 and December 19, 2011 when shares fell for seven-straight days, falling 4.3% (-$2.06) over that span.

(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)

Investing Insights: Will the iPad 3 Be the Next Catalyst for Apple’s Stock?